Cue Biopharma, Inc. (FRA:1UC)
Germany · Delayed Price · Currency is EUR 0.2440
-0.0030 (-1.21%)
At close: Jan 19, 2026
Cue Biopharma Revenue
Cue Biopharma had revenue of $2.15M USD in the quarter ending September 30, 2025, a decrease of -35.58%. This brings the company's revenue in the last twelve months to $7.10M, down -25.51% year-over-year. In the year 2024, Cue Biopharma had annual revenue of $9.29M with 69.16% growth.
Revenue (ttm)
$7.10M
Revenue Growth
-25.51%
P/S Ratio
4.25
Revenue / Employee
$173.17K
Employees
41
Market Cap
25.71M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.29M | 3.80M | 69.16% |
| Dec 31, 2023 | 5.49M | 4.25M | 340.96% |
| Dec 31, 2022 | 1.25M | -13.70M | -91.67% |
| Dec 31, 2021 | 14.94M | 11.79M | 373.68% |
| Dec 31, 2020 | 3.15M | -304.01K | -8.79% |
| Dec 31, 2019 | 3.46M | 2.32M | 202.67% |
| Dec 31, 2018 | 1.14M | - | - |
| Dec 31, 2017 | - | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- | 1.22B |
| edding AG | 149.67M |
| ACCENTRO Real Estate AG | 77.32M |
| Hyrican Informationssysteme Aktiengesellschaft | 24.26M |
| OTRS AG | 12.08M |
| Weng Fine Art AG | 2.48M |
| Rubean AG | 1.78M |
| Petro Matad | 1.73M |